Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson's Disease.

ElShagea, Hala N; Makar, Rana R; Salama, Alaa H; Elkasabgy, Nermeen A; Basalious, Emad B

ElShagea, Hala N; Makar, Rana R; Salama, Alaa H; Elkasabgy, Nermeen A; Basalious, Emad B.

Afiliación

ElShagea HN; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Cairo 12451, Egypt.
Makar RR; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Cairo 12451, Egypt.
Salama AH; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Cairo 12451, Egypt.
Elkasabgy NA; Pharmaceutical Technology Department, National Research Centre, Dokki, Cairo 12622, Egypt.
Basalious EB; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt.

Pharmaceutics ; 15(2)2023 Feb 05.

Article en En | MEDLINE | ID: mdl-36839855

Palabras clave

brain kinetics; drug delivery; mucoadhesion; nanotechnology; nose-to-brain delivery

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google